Respiratory Infections are infections affecting structures of the respiratory system, ranging from the nose, throat and upper airways to the bronchi, bronchioles and lungs. They include illnesses caused by viruses, bacteria, fungi and, less commonly, other microorganisms. The term is therefore a broad category rather than the name of one specific disease.
Upper respiratory infections primarily involve structures above the lower respiratory tract, whereas lower respiratory infections involve the bronchi, bronchioles or lung parenchyma and can be substantially more dangerous because they may impair gas exchange. Common symptoms include cough, sore throat, nasal congestion, runny nose, fever, sputum production, wheezing and fatigue, but manifestations depend on the anatomical site and pathogen. Some infections are mild and self-limiting, while others cause pneumonia, bronchiolitis, sepsis or respiratory failure. The clinical significance of a Respiratory Infection depends on the organism, route of transmission, host immunity, age, underlying lung function and whether infection spreads from the upper airway into the lower respiratory tract.
Viruses are responsible for a large proportion of acute Respiratory Infections, including infections caused by rhinoviruses, influenza viruses, respiratory syncytial virus, coronaviruses and other respiratory pathogens. Bacteria can cause pharyngitis, sinus infection, bronchitis, pneumonia and other conditions, although bacterial and viral symptoms often overlap. Fungal respiratory infections are less common and occur disproportionately in people with particular environmental exposures or impaired immunity.
Transmission varies by organism but may involve respiratory droplets, aerosols, contaminated hands and surfaces, or direct contact with respiratory secretions. Some pathogens have strong seasonal patterns because indoor crowding, temperature, humidity, host behaviour and population immunity alter transmission. People can sometimes transmit infection before or without obvious symptoms, which complicates prevention. The infectious dose, susceptibility of the host and efficiency of the organism's transmission mechanisms all influence whether exposure results in infection. Public-health measures such as ventilation, hand hygiene, staying away from others when acutely infectious and appropriate vaccination can reduce transmission for selected pathogens.
Once a respiratory pathogen reaches susceptible tissue, innate immune defences form the first line of protection. Nasal and airway mucus can trap particles, while coordinated ciliary movement transports secretions towards the pharynx. Coughing helps remove material from lower airways. Epithelial cells detect microbial components and release signalling molecules that recruit immune cells. Neutrophils, macrophages, natural killer cells and other components of innate immunity respond rapidly, while adaptive immune responses develop more specifically over time.
Inflammation produces many symptoms of infection, including mucus production, tissue swelling, fever and fatigue. In the lower respiratory tract, excessive inflammation can impair alveolar gas exchange and cause pneumonia. Viral infections can also damage respiratory epithelium and create conditions that favour secondary bacterial infection. Host immunity generally clears many infections without specific treatment, but immune suppression can allow prolonged replication, dissemination or opportunistic infection. The balance between pathogen replication and host inflammatory response therefore determines both disease severity and recovery.
Diagnosis depends on the anatomical site, severity and suspected pathogen. Many mild upper Respiratory Infections are diagnosed clinically without laboratory confirmation because testing would not change treatment. Molecular nucleic-acid amplification tests can identify viral or bacterial genetic material rapidly and are useful when knowing the specific pathogen will alter isolation, antiviral treatment, antimicrobial selection or clinical management. Antigen tests can provide rapid results for selected organisms but may have different sensitivity.
Cultures remain important for certain bacterial infections and for antimicrobial susceptibility testing, although they may be slower or difficult to obtain from some respiratory sites. Chest imaging is generally unnecessary for uncomplicated upper respiratory illness but becomes important when pneumonia or another serious lower-respiratory condition is suspected. Oxygen saturation, respiratory rate and mental status help identify physiological deterioration. The same symptom, such as cough, can arise from a simple viral upper-airway infection or a serious lower-respiratory disease, so diagnostic reasoning must account for severity and anatomical involvement rather than symptoms alone.
Treatment of Respiratory Infections is cause-specific when the cause can be established or strongly suspected. Many viral infections require supportive care such as rest, fluids and symptom management rather than antibiotics. Some viral diseases have effective antiviral treatments when administered at the appropriate stage and to appropriate patients. Bacterial infections may require antibiotics, but unnecessary antibiotic use contributes to adverse effects and antimicrobial resistance and does not improve viral illness.
Severe lower-respiratory infections can require oxygen, fluid management, respiratory support and treatment of complications. Antimicrobial choice should reflect the likely organism, local resistance patterns, allergy history, comorbidities and infection site. People with chronic respiratory disease can experience disproportionately severe deterioration during otherwise common infections, making prevention and early recognition particularly important. Treatment also depends on host factors such as age, pregnancy, immune status and organ function, meaning that a regimen appropriate for one person may be unsuitable for another.
Respiratory Infections can produce a range of complications. Viral upper-airway illness may be followed by bacterial sinus or middle-ear infection in selected circumstances, while lower-respiratory infection can progress to pneumonia and respiratory failure. Severe infection can trigger sepsis, particularly in vulnerable people. Exacerbations of Chronic Obstructive Pulmonary Disease, asthma and bronchiectasis are frequently precipitated by respiratory infections, making infection control important even when the pathogen does not cause pneumonia. People with impaired immunity may develop atypical infections or prolonged disease.
Infants and older adults can deteriorate rapidly because of limited respiratory reserve or atypical symptom presentation. Persistent cough after an acute infection does not necessarily indicate ongoing infection; airway inflammation can remain for weeks after the pathogen has been cleared. Conversely, worsening symptoms after initial improvement can indicate a complication or secondary infection. Monitoring the trajectory of illness is therefore as important as identifying the initial symptoms.
Prevention operates at both individual and population levels. Vaccination is available for several important respiratory pathogens and can reduce infection, severe disease or both depending on the vaccine and pathogen. Hand hygiene can reduce transmission through contaminated hands, while improved ventilation and avoidance of close contact during periods of high infectiousness can reduce exposure to airborne or droplet-transmitted pathogens. Smoking cessation improves respiratory defence mechanisms and reduces susceptibility to severe respiratory disease.
Adequate nutrition and management of chronic illnesses support immune and respiratory resilience. Infection-control practices in healthcare settings include appropriate isolation, personal protective equipment and environmental controls according to the organism and route of transmission. Antibiotic stewardship is also a form of prevention because limiting unnecessary antimicrobial exposure reduces selection pressure for resistant organisms. Public-health surveillance helps identify outbreaks, monitor circulating pathogens and guide vaccination and infection-control strategies.
Respiratory Infections have shaped medical history because respiratory transmission can support rapid spread through populations. Influenza pandemics, tuberculosis and more recent coronavirus outbreaks demonstrate how respiratory pathogens can have consequences far beyond individual illness. Modern molecular diagnostics, vaccination programmes, antiviral medicines, antibiotics, intensive respiratory support and epidemiological surveillance have transformed outcomes, but antimicrobial resistance and emerging pathogens remain continuing challenges.
A key conceptual distinction is between infection and colonisation: microorganisms can sometimes be present in respiratory secretions without causing active tissue-invasive disease, particularly in chronically diseased airways. Another distinction is between symptoms and aetiology; a cough, fever or coloured sputum does not by itself identify the responsible organism. Respiratory Infections therefore represent a broad field linking microbiology, immunology, pulmonology, infectious-disease medicine and public health. Accurate management depends on recognising the anatomical site of infection, estimating severity, identifying likely causes and applying treatment and prevention measures proportionate to the actual risk.
